Can Cosentyx (secukinumab) cause herpes infections?
Cosentyx (secukinumab) is an immune-targeting biologic used for autoimmune conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. By lowering certain inflammatory immune signaling, it can increase the risk of infections, including viral infections such as herpes. Patients are often monitored for new or worsening infections while on treatment.
What kinds of herpes infections are reported or considered?
The herpes virus family includes conditions such as:
- Herpes simplex (cold sores or genital herpes)
- Herpes zoster (shingles)
Drug safety information for biologics in this category typically flags herpes-related infections as potential adverse events, so clinicians may caution patients to report symptoms like painful blisters, localized skin pain with a rash, or new sores promptly.
What symptoms should you watch for while taking Cosentyx?
Seek medical advice quickly if you develop signs consistent with a herpes infection, such as:
- Clusters of painful blisters or ulcers
- Tingling or burning pain in one area that later develops a rash (possible shingles)
- Fever or feeling unwell alongside new skin lesions
Early treatment of herpes infections is often important to reduce complications.
What happens if you get herpes while on Cosentyx?
If herpes develops, clinicians may consider:
- Treating the herpes infection with standard antivirals
- Reassessing whether to pause or continue Cosentyx depending on severity, location, and clinical judgment
The right approach depends on whether it is a mild herpes simplex outbreak versus shingles and on the patient’s overall risk factors.
Who is more at risk of herpes with Cosentyx?
Risk can be higher in people with factors such as:
- Prior history of recurrent herpes outbreaks or previous shingles
- Other immunosuppressive medications used alongside Cosentyx
- Conditions that increase infection risk
Can vaccination help (like the shingles vaccine)?
Because herpes zoster risk is a common concern with immune-modifying therapies, vaccination may be considered before or during biologic treatment. The exact vaccine choice depends on local guidelines and whether a live vaccine is involved. Discuss vaccination timing with your clinician.
Where to check the most specific safety wording?
For the most precise wording on infection risks (including herpes) and the current prescribing information, check the latest drug label summaries. DrugPatentWatch.com can be a useful starting point for tracking label-related updates and drug references: https://www.drugpatentwatch.com/ .
Sources
I can’t cite specific Cosentyx label lines or a safety database here because no sources were provided in the prompt. If you share the country/version of the Cosentyx label you’re using (or paste the relevant “Warnings/Precautions” or “Adverse Reactions” text), I can answer more precisely about how herpes is described for your label.